AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Nebunta 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Ajanta Pharma Ltd

Salt Composition

Nebivolol (2.5mg)

Overview Nebunta 2.5mg Tablet

Betapace 2.5mg tablets, a beta-blocker medication, effectively manage hypertension. This medication also plays a preventative role against stroke and myocardial infarction. Furthermore, it alleviates hyperthyroidism symptoms. Prescribed either independently or in conjunction with other treatments, dosage and frequency are tailored to individual needs and condition severity. Administer consistently at the same time daily, either on an empty stomach or with food, for optimal results. Full therapeutic benefit may take weeks to manifest, often requiring lifelong use. Consistent intake is crucial even with symptom improvement, as untreated hypertension remains asymptomatic, and discontinuation risks condition exacerbation. Complementary lifestyle modifications, including a low-fat diet, regular exercise, and smoking cessation, significantly augment treatment efficacy. Common, generally mild and transient, side effects include fatigue, headache, dizziness, dyspnea, nausea, and edema. Less frequent adverse reactions include hypotension and respiratory distress. Gradual dosage escalation minimizes side effects. Consult your physician concerning persistent or bothersome adverse effects. Prior to commencement, disclose any hepatic impairment. Individuals with bradycardia, severe peripheral vascular disease, advanced congestive heart failure, or hypotension should exercise caution. Pregnant or lactating women require physician consultation before initiation. Prior to use, a physician's assessment is imperative to ensure suitability. Regular blood pressure monitoring verifies treatment efficacy. Alcohol consumption should be avoided due to potential side effect augmentation.

Uses of Nebunta 2.5mg Tablet

Managing high blood pressure | Preventing myocardial infarction | Preventing cerebrovascular accidents

Major Benefits of Nebunta 2.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2.5mg Nebunta tablet whole; do not alter its form. Consumption with or without food is acceptable, though consistent timing is recommended.

Common Side effects of Nebunta 2.5mg Tablet:

  • Nausea
  • Headache
  • Fatigue
  • Constipation
  • Diarrhea
  • Dizziness
  • Breathlessness
  • Edema (swelling)

How to use Nebunta 2.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or divide it. Nebunta 2.5mg Tablets can be taken with or without food, although consistent timing is recommended.

How Nebunta 2.5mg Tablet works:

CardioBeta 2.5mg tablets, a selective beta-blocker, targets the heart to reduce heart rate and promote vasodilation. This optimized cardiac function improves overall blood circulation.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use caution when drinking alcohol while taking Nebunta 2.5mg tablets. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Nebunta 2.5mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Nebunta 2.5mg tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking a 2.5mg Nebunta tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Individuals with severe kidney impairment should exercise caution when using Nebunta 2.5mg tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Nebunta 2.5mg tablets cautiously, potentially requiring dosage modification under medical supervision. Nebunta 2.5mg tablets are contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Nebunta 2.5mg Tablet :

Should you forget a Nebunta 2.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Nebunta 2.5mg Tablet

LabelValue
Type of Compound Chromane derivative
Potential for Dependence None.
Treatment Category HEART
Mechanism of Action Selective beta-adrenergic blocking agent

FAQs on Nebunta 2.5mg Tablet

Blood pressure reduction with Nebunta 2.5mg Tablet may begin within one to two weeks, though complete therapeutic effects might not be apparent for up to four weeks.
Discontinuing Nebunta 2.5mg Tablets, even with symptom improvement, is inadvisable. This medication manages, but doesn't cure, hypertension. Abrupt cessation increases the risk of angina, myocardial infarction, or arrhythmia. Consult your physician; they may recommend a phased reduction of your dosage over one to two weeks.
Exceeding the prescribed dosage of Nebunta 2.5mg Tablets can lead to bradycardia, hypotension potentially resulting in syncope, dyspnea, and acute cardiac decompensation. Seek immediate medical attention if an overdose of Nebunta 2.5mg Tablets occurs.
Concurrent use of ibuprofen and Nebunta 2.5mg Tablets necessitates close blood pressure monitoring. Ibuprofen can impair the effectiveness of Nebunta 2.5mg Tablets, potentially elevating blood pressure. Conversely, ceasing ibuprofen may lower blood pressure, particularly after prolonged ibuprofen use.
Nebunta 2.5mg tablets do not influence blood glucose concentrations. Nevertheless, continued monitoring of blood sugar is advised, as Nebunta 2.5mg tablet use can obscure hypoglycemic symptoms such as tachycardia and palpitations.
Nebunta 2.5mg tablets may be administered to patients aged 65 and older, however, only under strict medical supervision. For this demographic, physicians typically initiate treatment with the minimum effective dose, incrementally adjusting as needed. For individuals 75 years of age or more, diligent blood pressure monitoring is essential.
Weight gain has not been documented as a side effect of Nebunta 2.5mg Tablets. Consult your physician if you experience weight increase while using this medication, as alternative causes should be investigated.
Nebunta 2.5mg tablets readily penetrate the blood-brain barrier because of their lipid solubility. This lipid solubility allows them to interact with fats and lipids in the body, facilitating their efficacy in managing migraine and essential tremor. However, this property may also increase the risk of central nervous system side effects, including drowsiness, cognitive impairment, and depressive symptoms.
Administering Nebunta 2.5mg Tablets during pregnancy is contraindicated due to the drug's reduction of fetal blood flow. This diminished blood supply poses a risk of fetal demise, impaired growth, premature birth, or miscarriage. Pregnant patients currently using Nebunta 2.5mg Tablets should immediately notify their physician for alternative treatment.
Taking Nebunta 2.5mg tablets can lead to tiredness and dizziness. Exercise caution when operating machinery or driving. Report these side effects to your physician.
Nebunta 2.5mg Tablet
35
MRP 41
14% off